InflaRx N.V. (IFRX)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. This filer's financial year end could not be read from its revenue history, so quarters are labelled by the calendar. Amounts in EUR.

Revenue Annual

0 60K 120K 180K 2024: 165.8K 2025: 29.3K 2024 2025

Gross Profit Annual

-7.5M -5M -2.5M 0 2.5M 5M 7.5M 2024: -3.2M 2025: -7.2M 2024 2025

Operating Income Annual

-60M -40M -20M 0 20M 40M 60M 2022: -32.2M 2023: -44.9M 2022 2023

Net Income Annual

-60M -40M -20M 0 20M 40M 60M 2024: -46.1M 2025: -45.6M 2024 2025

Cost of Revenue Annual

0 2.5M 5M 7.5M 2024: 3.3M 2025: 7.3M 2024 2025

Operating Cash Flow Annual

-60M -40M -20M 0 20M 40M 60M 2024: -48.6M 2025: -35.3M 2024 2025

Free Cash Flow Annual

-60M -40M -20M 0 20M 40M 60M 2024: -48.6M 2025: -35.4M 2024 2025

Operating cash flow minus capital expenditure.

Shares Outstanding Annual

0 25M 50M 75M 2024: 58.9M 2025: 67.3M 2024 2025

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.